| Literature DB >> 33824610 |
Dong Peng1, Ying-Ying Zou1, Yu-Xi Cheng1, Wei Tao1, Wei Zhang1.
Abstract
PURPOSE: The purpose of the present study was to evaluate the effect of time (season, surgical starting time in the daytime, preoperative waiting time) on patients with gastric cancer.Entities:
Keywords: gastric cancer; season; surgical starting time; waiting time
Year: 2021 PMID: 33824610 PMCID: PMC8018433 DOI: 10.2147/RMHP.S294141
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1Inclusion and exclusion criteria of patients with gastric cancer.
Clinical Characteristics of the Patients
| Characteristics | No. 586 |
|---|---|
| Sex | |
| Male/Female | 418 (71.3%)/168 (28.7%) |
| Age, year (mean, SD) | 60.7 (± 10.7) |
| BMI, kg/m2 (mean, SD) | 23.2 (± 27.9) |
| Season of gastrectomy | |
| Spring/Summer/Autumn/Winter | 158 (27.0%)/157 (26.8%)/150 (25.6%)/121 (20.6%) |
| Comorbidity | 216 (36.9%) |
| Preoperative waiting time, day (median, range) | 10 (1–97) |
| Surgical starting time | |
| Midday/Non-midday | 132 (22.5%)/454 (77.5%) |
| Clinical stage I/II/III | 148 (25.3%)/196 (33.4%)/242 (41.3%) |
| Surgical procedure | |
| Distal gastrectomy/Total gastrectomy | 409 (69.8%)/177 (30.2%) |
| Reconstruction methods B-I/B-II/R-Y | 279 (47.6%)/116 (19.8%)/191 (32.6%) |
| Retrieved lymph nodes (median, range) | 21 (3–70) |
| Operation time, minutes (median, range) | 210.0 (70.0–895.0) |
| Estimated blood loss, mL (median, range) | 100.0 (5.0–7000.0) |
| Postoperative hospital stay, day (median, range) | 11 (3–159) |
| Pathological stage I/II/III/IV | 137 (23.4%)/97 (16.6%)/345 (58.9%)/7 (1.1%) |
Note: Variables are expressed as the mean ± SD, median or n (%).
Abbreviations: BMI, body mass index; B-I, Billroth I reconstruction; B-II, Billroth II reconstruction; R-Y, Roux-en-Y reconstruction.
Outcomes of Midday and Non-Midday Groups
| Variable | Midday Group (132) | Non-Midday Group (454) | P value |
|---|---|---|---|
| Retrieved lymph nodes (median, range) | 21 (7–47) | 20 (3–70) | 0.132 |
| Operation time, minutes (median, range) | 202.5 (70.0–478.0) | 215.0 (90.0–895.0) | 0.017* |
| Estimated blood loss, mL (median, range) | 100.0 (20.0–1000.0) | 100.0 (5.0–7000.0) | 0.826 |
| Postoperative hospital stay, day (median, range) | 11 (5–66) | 11 (3–159) | 0.424 |
| Complications | 47 | 120 | 0.048* |
Note: Variables are expressed as the median, *P-value <0.05.
Outcomes of Different Season
| Variable | Spring (158) | Summer (150) | Autumn (157) | Winter (121) | P value |
|---|---|---|---|---|---|
| Retrieved lymph nodes (median, range) | 20 (5–54) | 21 (6–49) | 21 (3–51) | 19 (3–70) | 0.765 |
| Operation time, minutes (median, range) | 205.0 (90.0–422.0) | 217.5 (95.0–599.0) | 210.0 (70.0–895.0) | 225.0 (95.0–385.0) | 0.385 |
| Estimated blood loss, mL (median, range) | 100 (5–2000) | 100 (20–7000) | 100 (10–4000) | 100 (10–2500) | 0.605 |
| Postoperative hospital stay, day (median, range) | 10 (3–114) | 11 (4–66) | 11 (5–62) | 11 (5–159) | 0.334 |
| Complications | 41 | 47 | 48 | 31 | 0.406 |
Note: Variables are expressed as the median.
Outcomes of Short and Long Preoperative Waiting Time Groups
| Variable | Short-Waiting Group (323) | Long-Waiting Group (263) | P value |
|---|---|---|---|
| Retrieved lymph nodes (median, range) | 20 (5–49) | 21 (3–70) | 0.273 |
| Operation time, minutes (median, range) | 210.0 (70.0–895.0) | 215.0 (90.0–422.0) | 0.594 |
| Estimated blood loss, mL (median, range) | 100.0 (10.0–4000.0) | 100.0 (5.0–7000.0) | 0.114 |
| Postoperative hospital stay, day (median, range) | 11 (3–114) | 10 (4–159) | 0.026* |
| Complications | 102 | 65 | 0.080 |
Note: Variables are expressed as the median, *P-value <0.05.
Figure 2Overall survival curves for patients undergoing gastrectomy. (A) Overall survival curves for the waiting groups among all patients. (B) Overall survival curves for the waiting groups among clinical stage I patients. (C) Overall survival curves for the waiting groups among clinical stage II patients. (D) Overall survival curves for the waiting groups among clinical stage III patients.
Multivariate Analyses for the Identification of Independent Prognostic Factors for Overall Survival in All Clinical Stage Gastric Cancer
| Variables | Multivariate Analyses | ||
|---|---|---|---|
| HR | 95%Cl | p | |
| Sex (male/female) | 1.003 | 0.690–1.459 | 0.987 |
| Age (year) | 1.017 | 1.001–1.033 | 0.040* |
| BMI (kg/m2) | 0.879 | 0.844–0.953 | <0.001** |
| Surgical starting time | 1.355 | 0.888–2.069 | 0.159 |
| Season of gastrectomy | 0.969 | 0.835–1.126 | 0.684 |
| Comorbidity | 1.049 | 0.741–1.484 | 0.788 |
| Preoperative waiting time (day) | 1.004 | 0.990–1.019 | 0.570 |
| Clinical stage (I/II/III) | 2.053 | 1.619–2.603 | <0.001** |
Notes: *P-value <0.05, **P-value <0.01.
Abbreviations: BMI, body mass index; HR, hazard ratio; CI, confidence interval.